ARTICLE | Politics, Policy & Law
Pharma industry may yet face Trump tariffs
Industry avoids tariff bullet, for now
April 4, 2025 1:22 AM UTC
Biopharmaceutical companies may have dodged the worst of President Donald Trump’s tariffs for now, but industry lobbyists are expecting the Trump administration to launch an investigation that could lead to the imposition of pharmaceutical-specific tariffs in the coming months.
President Trump exempted pharmaceuticals from Wednesday’s “reciprocal” tariffs, which start at a base rate of 10% and vary by country based on trade balances with the U.S...